HMGB1 and polycystic ovary syndrome: HMGB1 dysregulation has been extensively implicated in PCOS pathophysiology (Zhang et al., 2020; Zhu et al., 2020), and recent studies have linked elevated serum HMGB1 to impaired glucose metabolism in PCOS patients (Moghetti et al., 2023).